SouthState’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
SouthState's REGN Position: Q3 2026 in Review
SouthState increased its Regeneron Pharmaceuticals (REGN) stake by 9.5% in Q3 2026, buying an estimated $1.51K and bringing the position to 23 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #639.
SouthState first reported a position in REGN in Q3 2021 and has held it in 18 quarters since. The position peaked at $33K in Q1 2025. 1,229 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- SouthState held 23 shares of Regeneron Pharmaceuticals worth $17.4K as of Q3 2026.
- SouthState bought 2 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $1.51K.
- Regeneron Pharmaceuticals made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #639 holding.
- SouthState first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 18 quarters since.
- SouthState's Regeneron Pharmaceuticals position peaked at $33K in Q1 2025.
- 1,229 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.